Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Pepinh-MYD A soluble TLR5 is involved in PBLs activation and antibacterial immunity via ... 2023 Int J Biol Macromol. Feng J.X. et al. DOI: 10.1016/j.ijbiomac.2023.123208
Puromycin Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to... 2023 J Exp Clin Cancer Res. Deng M. et al. DOI: 10.1186/s13046-022-02586-w
QUANTI-Blue™ Bacterial expression of a designed single-chain IL-10 prevents severe lung in... 2023 Mol Syst Biol. Montero-Blay A. et al. DOI: 10.15252/msb.202211037
QUANTI-Luc™: Luciferase Detection Reagent Chlamydia trachomatis relies on the scavenger role of aryl hydrocarbon recept... 2023 Microbes Infect. Zhang S. et al. DOI: 10.1016/j.micinf.2022.105097
Mouse TLR2 Reporter HEK293 Cells (NF-κB) Dietary iron restriction protects against vaso-occlusion and organ damage in ... 2022 Blood Li H. et al. DOI: 10.1182/blood.2022016218
R848 (Resiquimod) Omicron variants breakthrough infection elicited higher specific memory immun... 2023 Virol Sin. Yu P. et al. DOI: 10.1016/j.virs.2022.12.008
Flagellin FliC VacciGrade™ The Spike protein of SARS-CoV-2 signals via Tlr2 in zebrafish. 2022 Dev Comp Immunol. Tyrkalska S.D. et al. DOI: 10.1016/j.dci.2022.104626
pFUSE2-CLIg-hK Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of ne... 2022 NPJ Vaccines Tran T.T. et al. DOI: 10.1038/s41541-022-00586-7
QUANTI-Blue™ Calmodulin as a Key Regulator of Exosomal Signal Peptides. 2022 Cells Ono K. et al. DOI: 10.3390/cells12010158
LPS-PG (Lipopolysaccharide from P. gingivalis) Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carci... 2022 Int J Mol Sci. Imamura Y. et al. DOI: 10.3390/ijms24010697
293/TLR4-MD2-CD14 Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carci... 2022 Int J Mol Sci. Imamura Y. et al. DOI: 10.3390/ijms24010697
MDP Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. 2022 J Neuroinflammation Chen C. et al. DOI: 10.1186/s12974-022-02682-w
MSU Crystals Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. 2022 J Neuroinflammation Chen C. et al. DOI: 10.1186/s12974-022-02682-w
FLA-ST (Standard or Ultrapure) Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. 2022 J Neuroinflammation Chen C. et al. DOI: 10.1186/s12974-022-02682-w
Poly(dA:dT) Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. 2022 J Neuroinflammation Chen C. et al. DOI: 10.1186/s12974-022-02682-w
Poly(I:C) (HMW) VacciGrade™ Poly(I:C) treatment prevents skin tumor formation in the preclinical HPV8 tra... 2022 J Invest Dermatol. Hufbauer M. et al. DOI: 10.1016/j.jid.2022.12.007
Hygromycin B Gold Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriati... 2022 Cell Rep. Veras F.P. et al. DOI: 10.1016/j.celrep.2022.111897
QUANTI-Blue™ Synthesis and evaluation of a new class of MIF-inhibitors in activated macrop... 2022 Eur J Med Chem. Garai J. et al. DOI: 10.1016/j.ejmech.2022.115050
RAW-Blue™ Cells Synthesis and evaluation of a new class of MIF-inhibitors in activated macrop... 2022 Eur J Med Chem. Garai J. et al. DOI: 10.1016/j.ejmech.2022.115050
Poly(I:C) HMW CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment res... 2022 Cell Rep. Tilsed C.M. et al. DOI: 10.1016/j.celrep.2022.111874

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty